2023•PubMedRequires access

[Factors Influencing and Adverse Reactions of Voriconazole Clearance in Patients with Hematological Diseases].

Hegui Huang, Hailin Wang, Yi-Kai Lin, Yan-Dong Yi, Min Liu, Junli Dong, Jianmin Liu, Fan Chen, Ti-Ying Deng, Song Hu

Open publisher page 2 citations

Abstract

OBJECTIVE: ) in patients with hematological diseases, and evaluate the factors influencing and adverse reactions of voriconazole clearance in patients with hematological diseases, so as to provide a theoretical basis for reasonable clinical use of voriconazole. METHODS: after glucocorticoid treatment was also detected. In addition, stratified analysis was used to explore the adverse events of voriconazole. RESULTS: =4.318, P=0.038). CONCLUSION: of patients with hematological diseases, and adjust the dosage in time to reduce adverse reactions.

About this research paper

What this paper is about

OBJECTIVE: ) in patients with hematological diseases, and evaluate the factors influencing and adverse reactions of voriconazole clearance in patients with hematological diseases, so as to provide a theoretical basis for reasonable clinical use of voriconazole. METHODS: after glucocorticoid treatment was also detected. In addition, stratified analysis was used to explore the adverse events of voriconazole. RESULTS: =4.318, P=0.038). CONCLUSION: of patients with hematological diseases, and adjust the dosage in time to reduce adverse reactions.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: ) in patients with hematological diseases, and evaluate the factors influencing and adverse reactions of voriconazole clearance in patients with hematological diseases, so as to provide a theoretical basis for reasonable clinical use of voriconazole. METHODS: after glucocorticoid treatment was also detected. In addition, stratified analysis was used to explore the adverse events of voriconazole. RESULTS: =4.318, P=0.038). CONCLUSION: of patients with hematological diseases, and adjust the dosage in time to reduce adverse reactions.

Key concepts: Cmin, Voriconazole, Medicine, Internal medicine, Adverse effect, Albumin, Gastroenterology, Pharmacokinetics

Related papers

Back to paper searchBrowse research topicsOriginal source
[Factors Influencing and Adverse Reactions of Voriconazole Clearance in Patients with Hematological Diseases]. — Research Paper | ScholarLens